Charles Sawyers and colleagues have conducted a small early-stage clinical study to assess target modulation by the small-molecule inhibitor rapamycin. Rapamycin is approved to treat renal cancer ...
Rapamycin is an immunosuppressive agent with less-severe adverse effects than ciclosporin; Farkas et al., therefore, compared the efficacy of rapamycin and ciclosporin for the treatment of ...
IVHealingSpa.com is thrilled to announce the launch of two innovative wellness products: Enclomiphene, a testosterone-boosting supplement, and Topical Rapamycin Cream, a revolutionary anti-aging ...